Sinclair’s Life Biosciences Secures $80M for Groundbreaking Epigenetic Trial
Sinclair’s groundbreaking $80 million funding signals a pivot toward epigenetic therapies as the future of age-related treatment.
longevity
Why Tech Bros’ $100M Anti-Aging Quest is Misguided: Lessons in Longevity
Tech focuses too much on high-cost anti-aging solutions. Learn why lifestyle choices have a greater impact on longevity.
Sinclair’s Life Biosciences Secures $80M to Pioneer Gene Therapy Trials
Sinclair’s Life Biosciences secures $80M, highlighting a significant shift in innovative longevity therapies and gene therapy.
Why Listening to Silicon Valley’s Longevity Obsession Could Shorten Lives
Discover why lifestyle choices, not tech, drive longevity. Learn how community and habits can outlast Silicon Valley’s promises.
Proline’s Potential: Restoring Mitochondrial Function in Aging Cells
Discover how proline is proving essential in restoring mitochondrial function and combating aging.
Can Anti-Aging Breakthroughs Create a 2 Billion Population Surge by 2050?
Discover the implications of anti-aging breakthroughs on population growth and resource management by 2050.